TUG1 is also downregulated in glioma tissues, which negatively correlates with WHO tumor grade, tumor size, and patient survival [140], and suppresses miR-26a, which is particularly amplified in high-grade glioma tissue [141]. The gene discussed is TUG1; the disease is central nervous system cancer.